PMS51 - COST-EFFECTIVENESS OF TOFACITINIB-CONTAINING SEQUENCES FOR RHEUMATOID ARTHRITIS PATIENTS IN SPAIN
Abstract
The study aimed to determine the cost-effectiveness of initiating tofacitinib treatment in patients with moderate to severe rheumatoid arthritis (RA) previously treated with methotrexate (MTX) and showing inadequate response to a second-line therapy with any anti-tumor-necrosis-factor Alpha (TNF-IR population), in comparison to alternative treatment sequences excluding tofacitinib. A patient-level microsimulation model was customized to estimate...
Paper Details
Title
PMS51 - COST-EFFECTIVENESS OF TOFACITINIB-CONTAINING SEQUENCES FOR RHEUMATOID ARTHRITIS PATIENTS IN SPAIN
Published Date
Oct 1, 2018
Journal
Volume
21
Pages
S296 - S296
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History